jolney

HAPP has interesting prospects

jolney 已更新   
NASDAQ:HAPP   None
In looking at Happiness Biotech Group, I see some potential.

From TOS analysis
- Price/Book .5231
- P/E 6.67
- Free Cash Flow per Share $.52

If Happiness Biotech could return $.52 for the next 3 years, it would essentially generate almost enough free cash flow to cover the cost of stock at $1.74 per share. I really don't think that this stock could get much cheaper in a rational market. Additionally, it looks like the support level is about $1.69 per share which may be a good entry point if it hits that level.

Additionally, they had some good news with a launch of their cross-border ecommerce platform and record sales in March of $14M.

Not investment advice, just my perspective.
评论:
This one has been a panful lesson. I still hold a position in this company, but it never seemed to materialize
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。